Specifically, CDK9 phosphorylates and regulates the nuclear/cytosolic translocation of Wilms’ tumor 1-associating protein (WTAP) and methyltransferase-like 3 (METTL3), contributing to ectopic lipid accumulation and inflammation as NASH progresses. The gene discussed is CDK9; the disease is metabolic dysfunction-associated steatohepatitis.